Company Profile - Progenity Inc

Introduction

Biora Therapeutics Inc (Biora Therapeutics), formerly Progenity Inc, is a biotechnology company. It develops oral biotherapeutics to replace injection with needle-free. The company's pipeline products portfolio includes PGN-600 and PGN-001 liquid formulations delivered with the drug delivery system for the treatment of ulcerative colitis; PGN-OB1 liquid formulation of anti-TNF-alpha monoclonal antibody delivered with the oral biotherapeutics delivery system for the treatment of autoimmune conditions; and PGN-OB2 liquid formulation. It develops smart capsule platforms recoverable sampling systems and PIL Dx for GI sampling and diagnostics. The company delivers therapeutics to the site of diseases in the gastrointestinal tract, ulcerative colitis, and inflammatory bowel disease. Biora Therapeutics is headquartered in San Diego, California, the US.